Speakers
Emily O’Brien, PhD, FAHA
Associate Professor
Duke Clinical Research Institute
Duke University School of Medicine
Robert M. Califf, MD, MACC
Head of Clinical Policy and Strategy
Verily Life Sciences and Google Health
Topic
HERO-Learning Together about Vaccines for SARS-CoV-2
Keywords
COVID-19; Vaccine confidence; Side effects; Postmarketing surveillance; Long-term vaccine safety; Virus variants; PCORI; HERO Registry
Key Points
- In the United States to date, more than 100 million doses of COVID-19 vaccine have been administered. Yet there remains concern about the increase in variants of the coronavirus.
- Postmarket evidence generation around COVID-19 vaccines is critically important to understanding the long-term safety of vaccines and building confidence around their use.
- A “pod” is the group of people you live with or relate to as family and have regular household contact with at least once per week for the past 3 months.
Discussion Themes
What does it mean to be a “safe vaccine”?
We’re still learning about how families are navigating the psychosocial aspects of this pandemic.
Over time, manual processes will be replaced by algorithms and automated systems. But we need to develop digital technologies that support human interactions in health.
What will be the key issues around COVID-19 in 2022?
HERO-TOGETHER is a paid observational research study for people aged 18 and older working in healthcare who have received a COVID-19 vaccine. Eligible participants include anyone who works in a setting where people receive healthcare. Read more about the HERO Program and how to join the registry.
Tags
#pctGR, #HEROTOGETHER, @Collaboratory1, @heroesresearch